News for Healthier Living
RAS Inhibitor Daraxonrasib Demonstrates Initial Anti-Tumor Activity in Pancreatic Cancer
 Daraxonrasib is an oral, multi-selective RAS inhibitor from Revolution Medicines Data from this trial previously prompted the Food and Drug Administration (FDA) to grant orphan drug designation to daraxonrasib and the Phase 3 RASolute trial Therapy is being investigated in pancreatic cancer because of the high prevalence of RAS mutations and lack of effective therapies The targeted RAS inhibitor therapy daraxonrasib demonstrated the potential to improve patient outcomes over current standard treatments for patients with RAS-mutant pancreatic cancer, according to results of a Phase 1/2 trial led by researchers at The University of Texas MD Anderson Cancer Center.
May 6, 2026
May 7 2026May 6 2026May 5 2026May 4 2026May 1 2026 - Cold Hands, Warm Heart -- Researchers Solve Medical Mystery of Why TRPM4 Mutations Affect Skin and Heart Differently
- Study Links Cancer Metabolism to DNA Replication Errors
- Medicaid Restrictions Could Lead to Over 1 Million Missed Cancer Screenings
- New Research Shows Risks of Combining Cannabis Edibles and Alcohol Behind the Wheel
- Podcast: Focused Ultrasound for Brain Tumors and Neurodegenerative Diseases
- DDW 2026: Cedars-Sinai Experts Share Advances in Digestive Disease
- Tracking Environmental Arsenic Exposures Using Epigenetics
- Research Tip Sheet: Cancer, Pancreas Transplant, Cognitive Screening
- Turning a Hospital Stay into a Meaningful Bridge Back to HIV Care
- FDA Recalls Several Ghirardelli Powdered Beverages Over Potential Contamination
- High-Intensity Exercise After Breast Cancer Surgery Helps Speed Recovery
- Trump Offers Third Candidate For Surgeon General After Pulling Dr. Casey Means' Nomination
- Antibiotics Not Linked To Celiac Disease Risk, Study Argues
- Senses, Not Muscles, Key to Speech Recovery After Stroke
- Confusion Continues Over Age To Start Breast Cancer Screening, Survey Finds
- Common Knee Surgery Doesn't Help, Might Actually Make Things Worse, Clinical Trial Reports
- States Rush To Figure Out How To Enforce Trump's Medicaid Work Requirements
- Misinformation Puts Over 16 Million Americans at an Increased Risk for Skin Cancer
- ADHA Updates Workforce Position Statement, Calls for Practice-Level Action on Documented Retention Crisis
- May 2026 Issue of Neurosurgical Focus: "Cervical and Grade 2 Spondylolisthesis"
April 30 2026April 29 2026 - Toxic PCBs, sex-biased genes, and the developing brain
- The Medical Minute: Advances in Head and Neck Cancer Care Bring New Hope
- Helping Your Child Befriend an Autistic Peer
- Mayo Clinic AI Detects Pancreatic Cancer Up to 3 Years Before Diagnosis in Landmark Validation Study
- Mayo Clinic Study Finds Remote Monitoring May Detect Early Complications, Reduce Burden for Lung Transplant Patients
- Silver Spring Woman Becomes First Adult Sickle Cell Disease Patient in Maryland to Receive FDA-Approved Gene Therapy
- New Study Finds Urban Parks in Less Privileged Neighborhoods Are Smaller, Hotter and More Polluted
- Survey Finds Many Women Still Believe Mammograms Should Start at Age 50--Experts Say Age 40
- MRI Scans Link Eye Microvascular Health to Early Signs of Cognitive Decline
- Tumor-on-a-Chip Brings New Insight to Pancreatic Cancer
- Early-Career Researchers Show Off Science and Communication Skills at 2026 National Lab Research SLAM
- Study Finds People Wait an Average of 50 Days to See a Neurologist for the First Time
- AI Tool May Help Identify ADHD in Kids Long Before Typical Diagnosis
- FDA Moves to Real-Time Clinical Trial Patient Monitoring, Faster Drug Review
- Translational Experiments Advance Efforts to Restore Vision with Transplanted Neurons
- Your Nose Is a Battlefield
- New High-Risk Form of Diabetic Kidney Disease Linked to Immune Cells Revealed
- AI in Medicine is Not the End of Doctors, but a Warning to Put Empathy First, say SHRO Researchers in JAMA Opinion Article
- New Dual-Target Drug May Help Overcome Immunotherapy Resistance in Pancreatic Cancer
- Wake Forest Institute for Regenerative Medicine Team Discovers Gene Pattern That Could Help Doctors Identify Ebola Faster and More Accurately
- Preclinical Efficacy of Experimental Peptide Therapy Suggests a New Target for Metastatic Breast Cancer Treatments, UTHealth Houston Researchers Find
- Optimizing Exercise, Nutrition Before Surgery Boosts Patient Outcomes
- Patients in Low-Income Neighborhoods Are Less Likely to Receive Cancer Screenings
- Online Program Soothes Post-Trauma Stress In Injured Children
- Pooled Umbilical Cord Blood Boosts Stem Cell Transplant Success, Trial Finds
- Dementia Screening Safe For Families, Trial Finds
- Mental Defeat Can Worsen Chronic Pain, Researchers Say
- Challenging Diseases Addressed in Vol. 39 of SLAS Discovery
- A Study in French-Speaking Switzerland Reveals Significant and Persistent Psychological, Physical and Sexual Impacts
- Significant Rise in Valley Fever Cases in El Paso Linked to Extreme Weather, Dust, UTEP Study Finds
- New Research Challenges Understanding of mRNA Vaccines and Establishes Innovative Way to Make Them More Effective
- Research Aims to Fill Critical Gaps in Telehealth Design
- Researchers Spot Shifts in Firearm Suicide Risk and Seeking Treatment After 2020 Purchasing Surge
- Choosing Safer Diabetes Medications for Older Adults
- From Promise to Proof: Strengthening the Evidence Base for Digital Health Technologies
April 28 2026April 27 2026April 26 2026April 25 2026April 24 2026April 23 2026
|
|
|
|
|